Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis

Hamid, O., Lewis, K., Weise, A., McKean, M., Papadopoulos, K. P., Crown, J., Kim, T. M., Lakhani, N. J., Kaczmar, J., Kudchadkar, R., Spira, A., Rabinowits, G., Kim, K., Carvajal, R., Williamson, S., Ioffe, E., Chen, S., Mani, J., Jankovic, V., … Gullo, G. (2023). Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis. SKIN The Journal of Cutaneous Medicine, 7(2), s179. https://doi.org/10.25251/skin.7.supp.179
Authors:
Omid Hamid
Karl D. Lewis
Amy Weise
Meredith McKean
Kyriakos P. Papadopoulos
John Crown
Tae Min Kim
Nehal J. Lakhani
John M. Kaczmar
Ragini R. Kudchadkar
Alexander I. Spira
Guilherme Rabinowits
Kevin Kim
Richard D. Carvajal
Stephen K. Williamson
Ella Ioffe
Shuquan Chen
Jayakumar Mani
Vladimir Janković
Laura K. Brennan
Glenn S. Kroog
Tasha N. Sims
Israel Lowy
Giuseppe Gullo
Affiliated Authors:
Richard D. Carvajal
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.25251/skin.7.supp.179
DOI:
10.25251/skin.7.supp.179
Journal:
Skin
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: